Nebacumab
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Nebacumab is a human monoclonal antibody developed for the treatment of sepsis.[1] It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.[2]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ WHO: Consolidated List of Products
Script error: No such module "Check for unknown parameters".
Template:Monoclonals for infectious disease and toxins Template:Immune sera and immunoglobulins